- $75.33bn
- $98.03bn
- $199.13bn
- 63
- 78
- 28
- 58
Annual balance sheet for Elevance Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-Q | 10-K | 10-K | PRESS |
| Standards: | USG | USG | USG | USG | — |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 4,547 | 4,920 | 4,943 | 5,219 | 4,679 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Insurance Receivables | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Other Assets | |||||
| Total Assets | 97,460 | 102,755 | 108,928 | 116,889 | 121,494 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Policy Liabilities | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 61,400 | 66,512 | 69,622 | 75,574 | 77,612 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 36,060 | 36,243 | 39,306 | 41,315 | 43,882 |
| Total Liabilities & Shareholders' Equity | 97,460 | 102,755 | 108,928 | 116,889 | 121,494 |
| Total Common Shares Outstanding |